[HTML][HTML] A comprehensive review of amyotrophic lateral sclerosis

S Zarei, K Carr, L Reiley, K Diaz, O Guerra… - Surgical neurology …, 2015 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a late-onset fatal neurodegenerative disease affecting
motor neurons with an incidence of about 1/100,000. Most ALS cases are sporadic, but 5 …

Fatigue as a symptom or comorbidity of neurological diseases

IK Penner, F Paul - Nature Reviews Neurology, 2017 - nature.com
Fatigue, best described as an overwhelming feeling of tiredness and exhaustion, occurs in
the context of various neurological diseases. The high prevalence of fatigue as either a …

Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy

BM Kluger, LB Krupp, RM Enoka - Neurology, 2013 - AAN Enterprises
Fatigue is commonly reported in many neurologic illnesses, including multiple sclerosis,
Parkinson disease, myasthenia gravis, traumatic brain injury, and stroke. Fatigue contributes …

[HTML][HTML] Amyotrophic lateral sclerosis

MC Kiernan, S Vucic, BC Cheah, MR Turner, A Eisen… - The lancet, 2011 - thelancet.com
Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal neurodegenerative disease of the
human motor system. In this Seminar, we summarise current concepts about the origin of the …

Fatigue in healthy and diseased individuals

J Finsterer, SZ Mahjoub - American Journal of Hospice and …, 2014 - journals.sagepub.com
Objectives: Although fatigue is experienced by everyone, its definition and classification
remains under debate. Methods: A review of the previously published data on fatigue …

Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease

JH Friedman, G Alves, P Hagell, J Marinus… - Movement …, 2010 - Wiley Online Library
Fatigue has been shown to be a consistent and common problem in Parkinson's disease
(PD) in multiple countries and cultures. It is one of the most disabling of all symptoms …

Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: A systematic review and meta-analysis

ME Heidari, J Nadali, A Parouhan, M Azarafraz… - Journal of affective …, 2021 - Elsevier
Background Amyotrophic lateral sclerosis (ALS) people have a high risk of severe mental
disorders, like depression, which impacts their function, quality of life, and mobility. However …

Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis

S Paganoni, C Karam, N Joyce, R Bedlack… - …, 2015 - content.iospress.com
BACKGROUND: Amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) is a
neurodegenerative disease that results in progressive muscle weakness and wasting. There …

Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease

C Gibbons, F Pagnini, T Friede… - Cochrane Database of …, 2018 - cochranelibrary.com
Background Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease
(MND), is terminal, progressive neurological condition for which there are no curative …

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS

E Beghi, E Pupillo, V Bonito, P Buzzi… - … Lateral Sclerosis and …, 2013 - Taylor & Francis
Our objective was to assess the effects of acetyl-L-carnitine (ALC) with riluzole on disability
and mortality of amyotrophic lateral sclerosis (ALS). Definite/probable ALS patients, 40− 70 …